CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 ...
Hosted on MSN25d
ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?Masks and other businesses revenues increased ... Meanwhile, Device sales remain robust, driven by the combined availability of both AirSense 10 and AirSense 11 sleep devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results